Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07452692. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07452692
Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects
This study is not yet recruiting in Global. It is testing Skin Irritation and Sensitization of Selegiline TDS for depression.
DepressionOtherFrom 18 Years to 65 Years
Key information made simple
This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
Your next step
The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve using a digital tool or support program and giving feedback through check-ins or assessments. The main fit is usually meeting the main study requirements, while common reasons not to take part include major medical issues that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Corium Innovations, Inc.
- Sponsor type
- Other organization
- Main activity
- digital app or tool
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects
- Condition
- Major Depressive Disorder (MDD)
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Corium Innovations, Inc.
- Location / country
- Global
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07452692
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07452692
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Corium Innovations, Inc.. Based on the sponsor name or official registry information, it appears to be another type of organization. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me